Ensemtx
1 known investors
ENSEM Therapeutics develops small molecule precision medicines for oncology using its Kinetic Ensemble platform, which combines computational and AI/deep learning methods with experimental techniques to identify cryptic binding pockets. The company focuses on structure-based drug design for high-value, difficult-to-drug targets.